Best Biopharma Outsourcing Companies in Toronto, Canada
The 32 best Biopharma Outsourcing companies in Toronto, Canada in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Biomind Labs.
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Toronto
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Biomind Labs Developer of novel pharmaceuticals targeting neurological disorders and related conditions | $6M | 61 mo ago | Public | — | 2005 | — | — |
| 2 | Liberum Provider of protein synthesizers manufacturing, pre-clinical research, and drug development services among… | $2M | 39 mo ago | Seed | — | 2019 | — | — |
| 3 | Quality Green Provider of medical cannabis | $2M | 95 mo ago | Deadpooled | Andrew Spasiw CEO | 2015 | — | — |
| 4 | Grey Wolf Animal Health Provider of animal healthcare solutions | $49K | 92 mo ago | Seed | — | 2015 | WordPressApple iCloud MailMicrosoft 365+30 | — |
| 5 | Dalton Integrated drug discovery, development and manufacturing services | — | 163 mo ago | Acquired | — | 1986 | SalesforceBootstrapCloudflare+8 | — |
| 6 | LMC Manna Research One of the largest networks of outpatient clinical research centers in North America | — | 172 mo ago | Late Stage | Mark Angelo CEO | 2005 | — | — |
| 7 | Accelera Canada Provider of advocacy, market access, and regulatory services for biopharma sector | — | — | Acquired | — | 2017 | — | — |
| 8 | Ancillarie Functional services for clinical drug development | — | — | Unfunded | Amiit Keshav Naik Founder and Chief Executive Officer | 2012 | WordPress Block EditorElementorWordPress+22 | — |
Top 6 Biopharma Outsourcing companies in Toronto
#1
Seed · Toronto, Ontario · founded 2019 · 3 employees$2Mraised▾
Developer of a biotechnology platform intended to democratize access to the fruits of synthetic biology. The company's platform uses proprietary molecular and hardware technology, protein synthesizers help to speed up the production of enzymes, therapeutics, and lab reagents, enabling clients to bring speed, scalability, and reduce cost.
- Jul 2023Seed$1.8M
- Jun 2020Seed$250K
#2
Public · Toronto, Ontario · founded 2005 · 5 employees$6Mraised▾
Developer of novel pharmaceuticals targeting neurological disorders and related conditions. The company focuses on transforming biomedical sciences knowledge into fast-acting and controlled-release drugs. Tailored drug delivery systems target specific therapeutic indications beyond mental health. Research and development aims to change lives by providing safe and efficient pharmaceuticals. The company adheres to strict scientific standards to protect patients and ensure reliable clinical trial results.
- Sep 2021Post IPO$6M
#3
Deadpooled · Toronto, Ontario · founded 2015 · 11 employees$2Mraised▾
Provider of medical cannabis
- Dec 2018Seed$2M
#4
Seed · Toronto, Ontario · founded 2015 · 19 employees$48.7Kraised▾
Provider of animal healthcare solutions
- Mar 2019Seed$48.7K
#5
Acquired · Toronto, Ontario · founded 1986 · 146 employees—raised▾
Dalton provides drug discovery, development, and manufacturing services to biotechnology and pharmaceutical clients around the world. They manufacture Active Pharmaceutical Ingredients (APIs), sterile injectables, finished drug products in vials or syringes, as well as solid oral dosage forms. APIs can be produced in gram to kilogram quantities, including sterile APIs. It also offers contract services at any stage of the regulatory process (phase I, II, III, or commercial). Development services include chemistry and process development, medicinal chemistry, custom drug conjugation, targeted drug delivery systems, analytical method development and validation, ICH stability testing, formulation, and polymorphism screening.
#6
Late Stage · Toronto, Ontario · founded 2005 · 302 employees—raised▾
LMC Manna Research is a network of trial sites that has been conducting clinical trials for over 20 years. The company merged with LMC Diabetes & Endocrinology (LMC) in 2015 to form one of the largest networks of integrated outpatient clinical research sites in North America. Together, they claim that they have over 40 years of experience in conducting more than 1500 clinical research studies (Phase I - IV clinical trials). They have special capabilities to conduct diabetes and metabolic Phase I clinical studies. Their sites have completed audits by FDA and Health Canada. They have a patient database which has access to 350,000+ patients. They offer their services for the conduct of trials in a wide range of therapeutic areas.
- 2012PE—
Funding & investor landscape
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Toronto is moving
A read on the academic research around Biotechnology in Toronto — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 63 papers.
- University of Toronto61
- Toronto General Hospital2
- Toronto Centre for Phenogenomics1
- Toronto Metropolitan University1
- Genome2
- Cancer research2
- Gene2
- Transcription factor2
- RNA-binding protein2
- Virus4
- Cell4
- Gene3
- Cell culture3
- Ethylene glycol2
- Nanoparticle3
- In vivo3
- Nanotechnology2
- Biodistribution2
- Toxicity2
Who's building biotechnology IP in Toronto
- ls travel retail north america4toronto
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.